Winning Globally: Building ANZ’s Collective Advantage

Australia and New Zealand have the ingredients to be clinical research leaders: regulatory agility in New Zealand, tax advantages in Australia, strong patient engagement, and a track record that global sponsors trust. The foundation and history are there – now it’s time to build on it. This session takes an honest look at what is needed to compete for trials globally, discussing regional barriers, collective strategies to address them, and building a compelling case for why ANZ should be a first choice.